SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RWReeves who started this subject2/20/2003 11:00:42 AM
From: nigel bates  Read Replies (2) of 684
 
VICL forecasting net loss between $24 and $28m in 2003.
Market cap is now way below cash + equivalents + marketable securities (and way below bv), even subtracting the prospective $28m loss.
Picked up a few today in the hope they might attract a CALP type bid.
In any event, can't see too much downside.
:-)

                               VICAL INCORPORATED
CONDENSED BALANCE SHEETS
(in thousands)

December 31, December 31,
2002 2001
(Unaudited)
Assets:
Cash and cash equivalents $32,609 $43,736
Marketable securities 78,904 90,351
Other current assets 5,894 4,636
Total current assets 117,407 138,723
Investment 800 5,000
Property and equipment, net 4,943 5,060
Other assets 6,276 5,712
$129,426 $154,495
Liabilities and Stockholders' Equity:
Current liabilities $10,800 $7,790
Long-term obligations 4,319 4,546
Stockholders' equity 114,307 142,159
$129,426 $154,495

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext